Colorectal cancer now represents the second commonest cause of death from cancer in Western countries and is strongly associated with a high fat intake, especially from animal sources.1 2 It has been shown experimentally in rodents that a diet high in saturated fat (20%) strongly promotes the formation of colorectal tumours induced by chemical carcinogens Fatty acids were analysed by a modification of a previously described method.'8 After thawing, aliquots of tissue were weighed (200-1000 mg) and homogenised on ice in 10 ml of 0 1 mmol/l Tris HC1 buffer (pH 8.9) in a Polytron homogeniser (setting=6) for 30 seconds. A 2 ml aliquot of tissue homogenate was placed in a screw topped glass tube to which was added 5 ml of methanol/6 molIl HC1 (5:1 by volume), and 0-2 ml of methanol containing 20 g/l of the antioxidant butylated hydroxytoluene, and the internal standard, margaric acid (17:0, 1 g/l). The fatty acids were transesterified by incubating at 90°C under nitrogen for four hours. After cooling, the fatty acid methyl esters were extracted into 8 ml of hexane and washed with saturated NaC 1 solution. The samples were dried over anhydrous sodium sulphate and evaporated to dryness under nitrogen at 37°C. The samples were then disolved in 0.2 ml of hexane and sealed in brown glass ampoules. They were stored at -20°C and analysed within one week. Fatty acid standards were prepared as described previously. '8 Fatty acid methyl esters were analysed by gas liquid chromatography using a Pye Unicam Series 304 chromatograph (Philips Scientific, Cambridge, UK) and a fused silica tube capillary column (50 m WCOT CPSil88, 0 33 mm internal diameter, Chrompak UK Ltd) with flame ionisation detection. The gases used were helium as the carrier gas (2.7 bar; flow rate 0-483 ml/ minute) with air and hydrogen for the detector. The injection temperature was set at 270°C for each run and the oven temperature was initially ramped at 2°C/minute from 150°C to 200°C, then ramped at 5°C/minute between 200°C and 240°C, and finally held for six minutes. Detection was at 3000C.
The fatty acids were identified from their retention times and based on the use of authentic fatty acid methyl ester standards. The coefficients of variation of the nine major fatty acid methyl esters of interest ranged from 0 9% to 3.6% for within batch variation and from 2-9% to 9. 1% for inter batch variation. 18 The results were expressed in absolute unitsthat is as mg fatty acid per g weight wet tissue, and were based on the mean of at least two traces. Relative values (%) are also given for comparison with other studies.
STATISTICAL ANALYSIS
The data were entered into the University of Birmingham mainframe computer (IBM3090) and analysed by analysis of variance. The significance of the F ratios was determined from tables (Documenta-Geigy). Significance was taken as p<0o05. *p<O-05; **p<OOl.
Discussion
To our knowledge, this is the first study to show compositional changes of fatty acids in human colorectal cancer. The fatty acid profile of the unaffected mucosa was similar to that of control subjects in a study of inflammatory bowel disease.'9 Also, the rectal mucosa fatty acid profile of patients undergoing surgery for haemorrhoidectomy was found not to differ from the normal rectal mucosa from patients with colorectal cancer ascertained by packed colunm chromatography, thereby excluding a mucosal lipid field change in these patients.9 Thus, the use of non-malignant mucosal fatty acids as a comparison for cancer tissue fatty acids is valid. Moreover, as diet may have subtle influences on colonic mucosal fatty acid profiles of both rodents" '2202' and humans (rather than age or sex),9 such a comparison will provide more precise information relating to cancer tissue per se. Consistent with experimental data,589 an increased arachidonic acid concentration was found in the cancer tissue. Given that this is the precursor ofseries 2 prostaglandins, it is relevant that PGE2 has been shown to be increased in human colorectal cancer tissue. 22 Evidence suggests that PGE2 in particular is a potent tumour promoter.'0 Not only has chemically induced colon carcinogenesis in rodents been significantly reduced by inhibitors of series 2 prostaglandins," 1223ut the growth ofthe human colonic cell lines COLO-320 and HT-29 implanted into nude mice is also reduced by dietary n-3 lipids.2425 Furthermore, the reduced tumour growth of colonic tumours is related to reduced tumour content of arachidonic acid by dietary n-3 lipids.'2 425Nevertheless, arachidonic acid and prostaglandins in colorectal cancer tissue obtained from patients remains to be established. In particular, it will be important to determine the activity of the cyclo-oxygenase systems involved as this is likely to be a more important determinant of prostaglandin synthesis than substrate availability.
In contrast to the hypothesis of Wood, Habib et al,'3'7 the stearic acid:oleic acid ratio was not reduced but increased. This is perhaps not surprising given that this ratio in red cells was not found to The basis for the increase in arachidonic acid values in the cancer tissue remains to be established. This increase could be due to increased conversion because of enhanced desaturase activity upon the precursors linoleic acid and bis homo-gamma-linolenic acid. 38 Alternatively, there may be decreased utilisation of arachidonic acid to form lipid peroxides or prostaglandins and leukotrienes. Clearly a combination ofthese processes may be occurring: thus it is possible that there is both increased delta-6-desaturase activity and prostanoid production along with decreased lipid peroxidation.
In conclusion, differences in the fatty acid content of human colorectal cancer tissue have been described. This study therefore justifies further investigations in order to determine the mechanism involved. 
